STOCK TITAN

Camden National (CAC) director awarded 279 shares under equity plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Camden National Corp director Larry K. Haynes received a stock grant as part of his board compensation. On 2026-06-18, he acquired 279 shares of common stock at $51.49 per share under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

Following this grant, Haynes directly holds 1,198 common shares and indirectly holds 3,217.888 common shares through a revocable trust. This reflects a routine, compensation-related equity award rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Haynes Larry K
Role null
Type Security Shares Price Value
Grant/Award Common Stock 279 $51.49 $14K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 1,198 shares (Direct, null); Common Stock — 3,217.888 shares (Indirect, By Revocable Trust)
Footnotes (1)
  1. [object Object]
Stock grant size 279 shares Common stock grant on 2026-06-18 in lieu of director fees
Grant valuation price $51.49 per share Reported value for 279-share equity award
Direct holdings after grant 1,198 shares Common stock directly held by Larry K. Haynes after transaction
Indirect trust holdings 3,217.888 shares Common stock held indirectly via revocable trust after transaction
2022 Equity and Incentive Plan and Amendment financial
"Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees."
Revocable Trust financial
"total_shares_following_transaction 3,217.8880, nature_of_ownership By Revocable Trust"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
Grant, award, or other acquisition financial
"transaction_code_description Grant, award, or other acquisition"
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Haynes Larry K

(Last)(First)(Middle)
2 ELM STREET

(Street)
CAMDEN MAINE 04843

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/18/2026A279(1)A$51.491,198D
Common Stock3,217.888IBy Revocable Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.
Remarks:
Christopher G. Hutchinson, POA06/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Camden National (CAC) director Larry K. Haynes report on this Form 4?

Larry K. Haynes reported receiving 279 Camden National common shares as a stock grant. The award was made under the company’s 2022 Equity and Incentive Plan and Amendment in lieu of cash director fees, reflecting routine, compensation-related equity rather than an open-market trade.

At what price was the Camden National (CAC) stock grant to Larry K. Haynes valued?

The 279-share stock grant to Larry K. Haynes was valued at $51.49 per share. This price is used for reporting the grant under Camden National Corporation’s 2022 Equity and Incentive Plan and Amendment, which delivered shares instead of paying traditional cash director fees.

How many Camden National (CAC) shares does Larry K. Haynes hold after this transaction?

After the transaction, Larry K. Haynes holds 1,198 Camden National common shares directly. He also has 3,217.888 common shares indirectly through a revocable trust, giving him both direct and trust-based exposure reported in this Form 4 filing.

Was the Camden National (CAC) Form 4 transaction a market buy or sell?

The Form 4 does not show a market buy or sell; it reports an acquisition coded “A.” Haynes received 279 shares as a grant under the 2022 Equity and Incentive Plan and Amendment, specifically in lieu of director fees, rather than through open-market trading.

What plan governed Larry K. Haynes’s Camden National (CAC) stock grant?

The stock grant was made under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment. According to the filing footnote, the 279 shares were acquired under this plan as compensation in lieu of director fees, aligning director pay partly with company equity.